Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).
about
Radiochemistry, PET Imaging, and the Internet of Chemical ThingsHigh affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selectionBatch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer.Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.Radiosyntheses using fluorine-18: the art and science of late stage fluorinationExtra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.Clinical markers for identifying cholinergic deficits in Parkinson's diseaseNon-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degenerationEnhanced radiosyntheses of [¹¹C]raclopride and [¹¹C]DASB using ethanolic loop chemistry.Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's DiseaseImaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [(11)C]PBR28 PETGait speed in Parkinson disease correlates with cholinergic degenerationThalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.Automated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.Current status of positron emission tomography radiotracers for serotonin receptors in humans.Positron emission tomography molecular imaging in late-life depression.Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome.Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.Copper-Mediated Radiofluorination of Arylstannanes with [18F]KF.A fully-automated one-pot synthesis of [18F]fluoromethylcholine with reduced dimethylaminoethanol contamination via [18F]fluoromethyl tosylate.Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception.Preparation and stability of ethanol-free solution of [18F]florbetapir ([18F]AV-45) for positron emission tomography amyloid imaging.Mentally stimulating activities associate with better cognitive performance in Parkinson disease.Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.(-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use.Color discrimination errors associate with axial motor impairments in Parkinson's disease.Green approaches to late-stage fluorination: radiosyntheses of (18)F-labelled radiopharmaceuticals in ethanol and water.
P2860
Q28069182-0AF55045-A8D7-4C89-A8D8-96C9BD83FE7FQ28241366-201627F5-FDBD-4333-ACF2-AEAEE2444826Q30542885-A0B5297D-F5A5-4A4C-8DE9-A2CD99BA34AFQ31114482-41A32D20-7EEA-41AD-BFDD-02039AB1FD1EQ34074437-3A2A2C5E-727B-4984-A35E-4D6C5359F80AQ34170501-52D58624-FDE5-4793-8787-5CEB97B1B8EFQ34423050-0A3D2BB2-DD3A-4A42-A304-C49B2E230D67Q35040454-F730DECA-E83E-4959-AB73-48962081345DQ35054623-794F4B60-6E35-48E3-923B-A79387D99608Q36103817-3971BA93-82AE-4EBC-9CC4-9703F1088861Q36446162-4B634F86-6A5D-4F43-B291-A87850D593B3Q36494215-B2504E3A-67AF-4A57-A3C9-45A34504117FQ37210950-732D7D2B-9126-46A4-BA34-427813A2BDDAQ37251657-C28DF2FB-A499-4864-93BC-EC6164510D96Q37511433-67D47228-05D6-4098-8D1A-E618DD397A40Q37722894-30DA7C9C-20B6-4E12-83EB-E363ECFB18E6Q38166961-72F47936-5734-4D7C-A937-536966A4DCB7Q38166965-88F5FCA4-4F22-4EF8-A4DE-DDE76F84A15FQ38176164-043B0625-98D2-4765-A3E9-CE51D7A2D296Q41288367-72887A7D-A7F6-4794-8A9D-403C10D11101Q41475217-EA9CD087-0A6D-4821-AD23-B6BB70F10E29Q41569105-354B435F-9A9C-4936-A7F9-D2EAC644C15AQ41840589-3BDC3AC7-F7A0-43B8-8C43-EFFE393690E7Q42713276-05EEE6BA-1611-4F59-ADA6-D9DBC852A870Q45889671-BFCE76BC-A226-4262-840E-31793202BA67Q47664765-89B2E497-A250-4B66-9067-B1351C9E206BQ48479735-2D03A11D-7D05-4367-A5DF-84F8A72974E6Q48839882-F0A8458D-F20C-4919-B470-D89F135DE38CQ49958990-554C78B8-15CF-4581-B46D-8AC67DE8ED3AQ50248094-2FCC186D-F11A-48BF-BFE6-A2F02249F8E5
P2860
Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Highlighting the Versatility o ...... cals using a Tracerlab FX(FN).
@ast
Highlighting the Versatility o ...... cals using a Tracerlab FX(FN).
@en
type
label
Highlighting the Versatility o ...... cals using a Tracerlab FX(FN).
@ast
Highlighting the Versatility o ...... cals using a Tracerlab FX(FN).
@en
prefLabel
Highlighting the Versatility o ...... cals using a Tracerlab FX(FN).
@ast
Highlighting the Versatility o ...... cals using a Tracerlab FX(FN).
@en
P2093
P2860
P356
P1476
Highlighting the Versatility o ...... icals using a Tracerlab FX(FN)
@en
P2093
Bradford D Henderson
Brian G Hockley
Henry C Padgett
Louis J M Tluczek
Raphaël Hoareau
P2860
P304
P356
10.1002/JLCR.1865
P577
2011-05-01T00:00:00Z